Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kristy G Kuplast"'
Autor:
Jennifer R. Molina, Joseph M. Gozgit, Melissa M. Vasbinder, Ryan P. Abo, Kaiko kunii, Kristy G. Kuplast-Barr, Bin Gui, Sunaina P. Nayak, Elena Minissale, Kerren K. Swinger, Tim J. Wigle, Alvin Z. Lu, Danielle J. Blackwell, Christina R. Majer, Yue Ren, Ellen Bamberg, Mario Niepel, Jan-Rung Mo, William D. Church, Ahmed S. Mady, Jeff Song, Zacharenia A. Varsamis, Luke Utley, Patricia E. Rao, Timoty J. Mitchison, Kevin W. Kuntz, Victoria M. Richon, Kristen McEachern, Heike Keilhack
Publikováno v:
Cancer Research. 82:2154-2154
Targeting cytosolic nucleic acid sensing pathways to activate the Type I interferon (IFN) response is an emerging therapeutic strategy being explored in oncology. The PARP family consists of seventeen enzymes that regulate fundamental biological proc
Autor:
J. Joshua Smith, Christina R. Majer, Michael John Munchhof, Roy M. Pollock, Nigel J. Waters, Kristy G Kuplast, Lei Jin, L. Danielle Johnston, Lawrence A. Reiter, Nathalie Rioux, Richard Chesworth, Margaret Porter Scott, Elayne Chan-Penebre, P. Ann Boriack-Sjodin, Robert A. Copeland, Mikel P. Moyer, Kenneth W. Duncan
Publikováno v:
ACS medicinal chemistry letters. 7(2)
The recent publication of a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) provides the scientific community with in vivo-active tool compound EPZ015666 (GSK3235025) to probe the underlying pharmacology of this key enzyme. Here
Autor:
Jesse Smith, David Soong, Kristy G Kuplast, Christine Thompson, Olena Barbash, Elayne Penebre, Rocio Montes de Oca, Christina R. Majer, Christopher L. Carpenter, Charles F. McHugh, Ryan G. Kruger, Kenneth W. Duncan, Robert A. Copeland, Richard Chesworth, Neil F. Johnson, Sarah Gerhart, Ping Zhang
Publikováno v:
Cancer Research. 75:LB-248
PRMT5 is responsible for symmetric dimethylation of arginine residues in glycine and arginine rich (GAR) motifs on a variety of cytosolic and nuclear proteins including histones, spliceosome components, regulators of translation, transcription factor
Autor:
Wilma Wasco, Kristy G. Kuplast, Nikhat F. Zaidi, Yuji Kajiwara, Kevin J. Washicosky, Joseph D. Buxbaum
Publikováno v:
Journal of neurochemistry. 98(4)
Calsenilin/potassium channel-interacting protein (KChIP)3/ downstream regulatory element sequence antagonist modulator (DREAM) is a neuronal calcium-binding protein that has been shown to have multiple functions in the cell, including the regulation
Autor:
Luke Utley, Kaiko Kunii, Danielle J. Blackwell, Ryan Abo, Jan-Rung Mo, Mario Niepel, Yue Ren, David Church, Joseph M. Gozgit, Kevin Wayne Kuntz, Patricia E. Rao, Kerren Kalai Swinger, Jeff Song, Melissa Vasbinder, Kristy Kuplast-Barr, Victoria M. Richon, Timothy J. Mitchison, Christina R. Majer, Alvin Lu, Bin Gui, Jennifer R. Molina, Elena Minissale, Heike Keilhack, Tim J. Wigle, Ellen Bamberg
Publikováno v:
Cancer Research. 81:48-48
Targeting cytosolic nucleic acid sensing pathways and the Type I interferon (IFN) response is an emerging therapeutic strategy being explored in oncology. The PARP family consists of seventeen enzymes that regulate fundamental biological processes in
Autor:
Kaiko Kunii, W. David Church, Danielle J. Blackwell, Kevin Wayne Kuntz, Tim J. Wigle, Kristen McEachern, Heike Keilhack, Yue Ren, Laurie B. Schenkel, Ellen Bamberg, Prashant Shambharkar, Melissa Vasbinder, Kristy Kuplast-Barr, Christina R. Majer, Joseph M. Gozgit, Jenkins L. Lemera, Luke Utley, Victoria M. Richon, Mario Niepel
Publikováno v:
Cancer Research. 81:1344-1344
CD38 is an ADP-ribosyl cyclase that converts NAD+ to ADP-ribose (ADPR) or cyclic ADPR (cADPR) and nicotinamide. The enzyme can exist in either an ecto- or endo-catalytic orientation with different sub-cellular localization, and therefore can regulate
Autor:
Zaidi, Nikhat F., Kuplast, Kristy G., Washicosky, Kevin J., Kajiwara, Yuji, Buxbaum, Joseph D., Wasco, Wilma
Publikováno v:
Journal of Neurochemistry; Aug2006, Vol. 98 Issue 4, p1290-1301, 12p, 3 Color Photographs, 5 Black and White Photographs, 1 Chart
Autor:
Danielle J. Blackwell, Ryan Abo, Christina R. Majer, Jan-Rung Mo, Victoria M. Richon, Yue Ren, Alvin Lu, Luke Utley, Zacharenia A. Varsamis, Tim J. Wigle, Mario Niepel, Bin Gui, Kevin Wayne Kuntz, Jeff Song, Kerren Kalai Swinger, Kaiko Kunii, William Church, Sunaina P. Nayak, Joseph M. Gozgit, Melissa Vasbinder, Ellen Bamberg, Patricia E. Rao, Kristy Kuplast-Barr, Heike Keilhack, Timothy J. Mitchison
Publikováno v:
Cancer Research. 80:3405-3405
Targeting cytosolic nucleic acid sensing pathways and the Type I interferon (IFN) response is an emerging therapeutic strategy being explored in oncology. PARP7 is a member of the monoPARP class of enzymes, which catalyze the transfer of single units
Autor:
Patricia E. Rao, Danielle J. Blackwell, Ryan Abo, Kaiko Kunii, Kristy Kuplast-Barr, W. David Church, Victoria M. Richon, Heike Keilhack, Melissa M. Vasbinder, Jan-Rung Mo, Luke Utley, Ellen Bamberg, Mario Niepel, Zacharenia A. Varsamis, Yue Ren, Alvin Lu, Timothy J. Mitchison, Tim J. Wigle, Christina R. Majer, Kevin Wayne Kuntz, Jeff Song, Kerren Kalai Swinger, Joseph M. Gozgit, Bin Gui, Sunaina P. Nayak
Publikováno v:
Cancer Research. 80:DDT02-01
RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways PARP7 is a monoPARP that catalyzes the transfer of single units of ADP-ribose onto substrates to change their function (MARylati